Background
Methods
Patients
Clinical evaluation and biochemical data
Liver biopsy
Ultrasonography
Measurement of liver stiffness (LS) and controlled attenuation parameter (CAP)
Statistical analysis
Results
Characteristics of patients
Characteristics | Patients (n = 40) |
---|---|
Femalea
| 28 (70.0%) |
Age, year b
| 53.1 ± 11.2 |
BMI, kg/m2b
| 25.6 ± 4.5 |
Waist circumference, cmb
| 88.4 ± 11.9 |
Hip circumference, cmb
| 97.9 ± 8.1 |
Chronic Hepatitis Ba
| 12 (30.0) |
Chronic Hepatitis Ca
| 5 (12.5) |
NAFLDa
| 8 (20) |
Othera
| 15 (37.5) |
Biochemical parameters | |
AST, U/Lb
| 71.9 ± 35.6 |
ALT, U/Lc
| 92.5 (59.5–153.5) |
FBS, mg/dlb
| 113.2 ± 41.4 |
Triglyceride, mg/dlb
| 117.7 ± 65.5 |
HDL, mg/dlb
| 50.4 ± 18.3 |
Characteristics | Patients (n = 40) |
---|---|
Liver biopsy | |
Fibrosis stage | |
F0/F1/F2/F3/F4a
| 17 (42.5)/9 (22.5)/4 (10.0)/8 (20.0)/2 (5) |
Steatosis stage | |
S0/S1/S2/S3a
| 22 (55.0)/11 (27.5)/4 (10.0)/3 (7.5) |
Transient elastography (Premeal) | |
CAP, dB/mb
| 249.7 ± 58.1 |
LS, kPac
| 11.9 (6–18.1) |
Ultrasonography | |
No fatty livera
| 17 (46) |
Mild fatty livera
| 14 (37.8) |
Moderate fatty livera
| 6 (16.2) |